Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Radius Health Inc. (RDUS)

10.8   -0.15 (-1.37%) 09-29 00:58
Open: 11.11 Pre. Close: 10.95
High: 11.11 Low: 10.16
Volume: 1,194,367 Market Cap: 502M
Radius Health, Inc. is a biopharmaceutical company, which engages in developing and commercializing endocrine therapeutics in the areas of osteoporosis and oncology. The company is headquartered in Waltham, Massachusetts and currently employs 398 full-time employees. The firm is focused on the developing therapeutics in the areas of osteoporosis, oncology and endocrine diseases. The firm's lead investigational product candidate, TYMLOS (abaloparatide-SC) injection is developed for the treatment of postmenopausal women with osteoporosis at high risk for fracture. The Company’s clinical pipeline also includes an investigational abaloparatide transdermal patch for potential use in osteoporosis and the investigational drug elacestrant (RAD1901) for potential use in hormone-driven and/or hormone-resistant breast cancer, and vasomotor symptoms in postmenopausal women. Its RAD140 is a non-steroidal, selective androgen receptor modulator (SARM). RAD140 is under development for potential use in hormone receptor positive breast cancer.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 11.124 - 11.178 11.178 - 11.231
Low: 10.011 - 10.074 10.074 - 10.137
Close: 10.675 - 10.782 10.782 - 10.887

Technical analysis

as of: 2020-09-28 4:36:47 PM
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 13.92     One year: 15.20
Support: Support1: 10.16    Support2: 8.45
Resistance: Resistance1: 11.92    Resistance2: 13.01
Pivot: 11.68
Moving Average: MA(5): 11.15     MA(20): 11.81
MA(100): 12.77     MA(250): 17.08
MACD: MACD(12,26): -0.30     Signal(9): -0.18
Stochastic oscillator: %K(14,3): 16.00     %D(3): 16.59
RSI: RSI(14): 37.03
52-week: High: 29.89  Low: 10.16  Change(%): -56.2
Average Vol(K): 3-Month: 64577  10-Days: 67216

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
RDUS has closed above bottom band by 9.2%. Bollinger Bands are 3.1% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Mon, 28 Sep 2020
Radius Health Inc. (RDUS) Settles Into New 52-Week Low on September 28 Session -

Sat, 26 Sep 2020
When is Radius Health, Inc. (RDUS) going to be good investment? - Marketing Sentinel

Thu, 24 Sep 2020
Radius Health Inc (RDUS) Stock: What Does the Chart Say? - InvestorsObserver

Thu, 24 Sep 2020
Radius Health Provides Business Update Nasdaq:RDUS - GlobeNewswire

Mon, 21 Sep 2020
Radius Health Inc (NASDAQ:RDUS) Receives Consensus Rating of "Hold" from Analysts - MarketBeat

Wed, 16 Sep 2020
Investors Purchase High Volume of Call Options on Radius Health (NASDAQ:RDUS) - MarketBeat

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Underperform Discounted cash flow: Outperform
Return on Assets: Underperform Price to Earnings: Underperform
Return on Equity: Outperform Debt to Equity: Underperform
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Drug Manufacturers General Specialty & Generic
Shares Out. (M) 46
Shares Float (M) 46
% Held by Insiders 0.37
% Held by Institutions 112.67
Shares Short (K) 7,200
Shares Short P. Month (K) 7,280

Stock Financials

EPS -2.950
EPS Est This Year -5.410
EPS Est Next Year -3.920
Book Value (p.s.) -2.360
Profit Margin -67.99
Operating Margin -56.36
Return on Assets (ttm) -33.7
Return on Equity (ttm)
Qtrly Rev. Growth 22.1
Gross Profit (p.s.) 3.401
Sales Per Share 4.314
EBITDA (p.s.) -2.388
Qtrly Earnings Growth
Operating Cash Flow (M) -75
Levered Free Cash Flow (M) -25

Stock Valuations

PE Ratio -3.66
PEG Ratio
Price to Book value -4.58
Price to Sales 2.50
Price to Cash Flow -6.71

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.